Interaction Checker

Interaksi Tamsulosin

Tamsulosin (Flomax), golongan penyekat alfa, memiliki 121 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 62 mayor, 40 moderat, 19 minor, dan 0 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Interaksi dari label

Interaksi mayor (62)

  • Alfuzosinpenyekat alfaMayor

    • Should not be used in combination with other alpha adrenergic blocking agents ( 5.2 , 7.2 , 12.3 ) (label Tamsulosin, Peringatan dan perhatian)

  • AmiodaronantiaritmiaMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Aprepitantpenghambat CYP3A4Mayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Asetazolamidpenghambat karbonat anhidraseMayor

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (label Tamsulosin, Peringatan dan perhatian)

  • AtazanavirantiretroviralMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Brinzolamidpenghambat karbonat anhidraseMayor

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (label Tamsulosin, Peringatan dan perhatian)

  • DarunavirantiretroviralMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Darunavir dan kobisistatantiretroviralMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Diklorfenamidpenghambat karbonat anhidraseMayor

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (label Tamsulosin, Peringatan dan perhatian)

  • Diltiazempenghambat kanal kalsiumMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Doksazosinpenyekat alfaMayor

    • Should not be used in combination with other alpha adrenergic blocking agents ( 5.2 , 7.2 , 12.3 ) (label Tamsulosin, Peringatan dan perhatian)

  • Dorzolamidpenghambat karbonat anhidraseMayor

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (label Tamsulosin, Peringatan dan perhatian)

  • Dorzolamid dan timololpenghambat karbonat anhidraseMayor

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (label Tamsulosin, Peringatan dan perhatian)

  • DronedaronantiaritmiaMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Dutasterid dan tamsulosinpenghambat 5-alfa reduktaseMayor

    • Should not be used in combination with other alpha adrenergic blocking agents ( 5.2 , 7.2 , 12.3 ) (label Tamsulosin, Peringatan dan perhatian)

  • EfavirenzantiretroviralMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Efavirenz, lamivudin, dan tenofovirantiretroviralMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Elvitegravir, kobisistat, emtrisitabin, dan tenofovirantiretroviralMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Eritromisinantibiotik makrolidaMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • EverolimusimunosupresanMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Fenoksibenzaminpenyekat alfaMayor

    • Should not be used in combination with other alpha adrenergic blocking agents ( 5.2 , 7.2 , 12.3 ) (label Tamsulosin, Peringatan dan perhatian)

  • Fentolaminpenyekat alfaMayor

    • Should not be used in combination with other alpha adrenergic blocking agents ( 5.2 , 7.2 , 12.3 ) (label Tamsulosin, Peringatan dan perhatian)

  • Flukonazolantijamur azolMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • FosamprenavirantiretroviralMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Fosaprepitantpenghambat CYP3A4Mayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • IloperidonantipsikotikMayor

    Avoid coadministration of FANAPT with alpha-adrenergic blocking agents and adjust medications that affect blood pressure as needed [see Warnings and Precautions (5.7) ] . (label Iloperidon, Interaksi obat)

  • Imatinibpenghambat CYP3A4Mayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • IsoniazidantibiotikMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Itrakonazolantijamur azolMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Ivakaftorpenghambat CYP3A4Mayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Karvedilolpenyekat betaMayor

    • Should not be used in combination with other alpha adrenergic blocking agents ( 5.2 , 7.2 , 12.3 ) (label Tamsulosin, Peringatan dan perhatian)

  • Ketokonazolantijamur azolMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Klaritromisinantibiotik makrolidaMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Labetalolpenyekat betaMayor

    • Should not be used in combination with other alpha adrenergic blocking agents ( 5.2 , 7.2 , 12.3 ) (label Tamsulosin, Peringatan dan perhatian)

  • LenakapavirantiretroviralMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Lopinavir dan ritonavirantiretroviralMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Metazolamidpenghambat karbonat anhidraseMayor

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (label Tamsulosin, Peringatan dan perhatian)

  • Mifepristonpenghambat CYP3A4Mayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Mirabegronagonis beta-adrenergikMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • NefazodonantidepresanMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Nirmatrelvir dan ritonavirantivirusMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Palbosiklibpenghambat CYP3A4Mayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Perak sulfadiazinsulfonamidaMayor

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (label Tamsulosin, Peringatan dan perhatian)

  • PerampanelantikonvulsanMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Posakonazolantijamur azolMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Prazosinpenyekat alfaMayor

    • Should not be used in combination with other alpha adrenergic blocking agents ( 5.2 , 7.2 , 12.3 ) (label Tamsulosin, Peringatan dan perhatian)

  • Ranolazinobat yang memperpanjang interval QTMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • RitonavirantiretroviralMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • SenobamatantikonvulsanMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • SiklosporinimunosupresanMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Silodosinpenyekat alfaMayor

    • Should not be used in combination with other alpha adrenergic blocking agents ( 5.2 , 7.2 , 12.3 ) (label Tamsulosin, Peringatan dan perhatian)

  • Simetidinpenghambat H2Mayor

    Tamsulosin hydrochloride capsules should be used with caution in combination with cimetidine, particularly at a dose higher than 0.4 mg (e.g., 0.8 mg) [see Drug Interactions ( 7.1 ) and Clinical Pharmacology ( 12.3 )] Tamsulosin hydrochloride capsules should not be used in combination with other alpha adrenergic blocking agents [see Drug Interactions ( 7.2 )… (label Tamsulosin, Peringatan dan perhatian)

  • SulfadiazinsulfonamidaMayor

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (label Tamsulosin, Peringatan dan perhatian)

  • Sulfametoksazol dan trimetoprim (kotrimoksazol)sulfonamidaMayor

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (label Tamsulosin, Peringatan dan perhatian)

  • SulfasalazinsulfonamidaMayor

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (label Tamsulosin, Peringatan dan perhatian)

  • Suvoreksantsedatif-hipnotikMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Tadalafilpenghambat PDE5Mayor

    CIALIS is not recommended in combination with alpha-blockers for the treatment of BPH because efficacy of the combination has not been adequately studied and because of the risk of blood pressure lowering. (label Tadalafil, Peringatan dan perhatian)

  • Terazosinpenyekat alfaMayor

    • Should not be used in combination with other alpha adrenergic blocking agents ( 5.2 , 7.2 , 12.3 ) (label Tamsulosin, Peringatan dan perhatian)

  • TikagrelorantiplateletMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Verapamilpenghambat kanal kalsiumMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • Vorikonazolantijamur azolMayor

    • Should not be used in combination with strong inhibitors of CYP3A4. (label Tamsulosin, Peringatan dan perhatian)

  • ZonisamidantikonvulsanMayor

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (label Tamsulosin, Peringatan dan perhatian)

Interaksi moderat (40)

  • Abirateronpenghambat CYP2D6Moderat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Alopurinolpenghambat xantin oksidaseModerat

    Digoxin and Theophylline Dosage adjustments are not necessary when a tamsulosin hydrochloride capsule is administered concomitantly with digoxin or theophylline [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • AminofilinmetilxantinModerat

    Digoxin and Theophylline Dosage adjustments are not necessary when a tamsulosin hydrochloride capsule is administered concomitantly with digoxin or theophylline [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • Atenololpenyekat betaModerat

    Nifedipine, Atenolol, Enalapril Dosage adjustments are not necessary when tamsulosin hydrochloride capsules are administered concomitantly with nifedipine, atenolol, or enalapril [see clinical pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • Atenolol dan klortalidonpenyekat betaModerat

    Nifedipine, Atenolol, Enalapril Dosage adjustments are not necessary when tamsulosin hydrochloride capsules are administered concomitantly with nifedipine, atenolol, or enalapril [see clinical pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • Avanafilpenghambat PDE5Moderat

    Caution is advised when alpha adrenergic blocking agents including tamsulosin hydrochloride are coadministered with PDE5 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • BupropionantidepresanModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Butalbital, aspirin, dan kafeinbarbituratModerat

    Digoxin and Theophylline Dosage adjustments are not necessary when a tamsulosin hydrochloride capsule is administered concomitantly with digoxin or theophylline [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • Butalbital, aspirin, kafein, dan kodeinbarbituratModerat

    Digoxin and Theophylline Dosage adjustments are not necessary when a tamsulosin hydrochloride capsule is administered concomitantly with digoxin or theophylline [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • Butalbital, parasetamol, dan kafeinbarbituratModerat

    Digoxin and Theophylline Dosage adjustments are not necessary when a tamsulosin hydrochloride capsule is administered concomitantly with digoxin or theophylline [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • Butalbital, parasetamol, kafein, dan kodeinbarbituratModerat

    Digoxin and Theophylline Dosage adjustments are not necessary when a tamsulosin hydrochloride capsule is administered concomitantly with digoxin or theophylline [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • DarifenasinantikolinergikModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Dekstrometorfan dan kuinidinobat serotonergikModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • DifenhidraminantihistaminModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Digoksinglikosida digitalisModerat

    Digoxin and Theophylline Dosage adjustments are not necessary when a tamsulosin hydrochloride capsule is administered concomitantly with digoxin or theophylline [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • DuloksetinSNRIModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Enalaprilpenghambat ACEModerat

    Nifedipine, Atenolol, Enalapril Dosage adjustments are not necessary when tamsulosin hydrochloride capsules are administered concomitantly with nifedipine, atenolol, or enalapril [see clinical pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • Enalapril dan hidroklorotiazidpenghambat ACEModerat

    Nifedipine, Atenolol, Enalapril Dosage adjustments are not necessary when tamsulosin hydrochloride capsules are administered concomitantly with nifedipine, atenolol, or enalapril [see clinical pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • Ergotamin dan kafeinalkaloid ergotModerat

    Digoxin and Theophylline Dosage adjustments are not necessary when a tamsulosin hydrochloride capsule is administered concomitantly with digoxin or theophylline [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • Febuksostatpenghambat xantin oksidaseModerat

    Digoxin and Theophylline Dosage adjustments are not necessary when a tamsulosin hydrochloride capsule is administered concomitantly with digoxin or theophylline [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • FluoksetinSSRIModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Furosemiddiuretik loopModerat

    While furosemide produced an 11% to 12% reduction in tamsulosin hydrochloride C max and AUC, these changes are expected to be clinically insignificant and do not require adjustment of the tamsulosin hydrochloride capsules dosage [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • KlobazambenzodiazepinModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • KuinidinantiaritmiaModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Naltrekson dan bupropionantagonis opioidModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Nifedipinpenghambat kanal kalsium dihidropiridinModerat

    Nifedipine, Atenolol, Enalapril Dosage adjustments are not necessary when tamsulosin hydrochloride capsules are administered concomitantly with nifedipine, atenolol, or enalapril [see clinical pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • Nilotinibobat yang memperpanjang interval QTModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Olanzapin dan fluoksetinantipsikotikModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Orfenadrin, aspirin, dan kafeinpelemas ototModerat

    Digoxin and Theophylline Dosage adjustments are not necessary when a tamsulosin hydrochloride capsule is administered concomitantly with digoxin or theophylline [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • ParoksetinSSRIModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • PentoksifilinmetilxantinModerat

    Digoxin and Theophylline Dosage adjustments are not necessary when a tamsulosin hydrochloride capsule is administered concomitantly with digoxin or theophylline [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • PropafenonantiaritmiaModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Propranololpenyekat betaModerat

    Alpha Blockers: Co-administration of beta-blockers with alpha-blocker (e.g., prazosin) has been associated with prolongation of first dose hypotension and syncope. (label Propranolol, Interaksi obat)

  • Rolapitantpenghambat CYP2D6Moderat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Sildenafilpenghambat PDE5Moderat

    Caution is advised when alpha adrenergic blocking agents including tamsulosin hydrochloride are coadministered with PDE5 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Sinakalsetpenghambat CYP2D6Moderat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • TeofilinmetilxantinModerat

    Digoxin and Theophylline Dosage adjustments are not necessary when a tamsulosin hydrochloride capsule is administered concomitantly with digoxin or theophylline [see Clinical Pharmacology ( 12.3 )] . (label Tamsulosin, Interaksi obat)

  • TerbinafinantijamurModerat

    Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 poor metabolizers, or in combination with other cytochrome P450 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • Vardenafilpenghambat PDE5Moderat

    Caution is advised when alpha adrenergic blocking agents including tamsulosin hydrochloride are coadministered with PDE5 inhibitors. (label Tamsulosin, Peringatan dan perhatian)

  • WarfarinantikoagulanModerat

    • Exercise caution with concomitant administration of warfarin ( 5.2 , 7.4 , 12.3 ) (label Tamsulosin, Peringatan dan perhatian)

Penyebutan minor (19)

  • Alprostadilanalog prostaglandinMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • Dutasteridpenghambat 5-alfa reduktaseMinor

    Coadministration of dutasteride and tamsulosin resulted in similar changes to serum PSA as dutasteride monotherapy. (label Dutasterid, Peringatan dan perhatian)

  • EpinefrinsimpatomimetikMinor

    • Drugs that counter the pressor effects of epinephrine include alpha blockers, vasodilators such as nitrates, diuretics, antihypertensives, and ergot alkaloids. (label Epinefrin, Interaksi obat)

  • Epoprostenolanalog prostaglandinMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • Esmololpenyekat betaMinor

    Use in Patients with Pheochromocytoma If BREVIBLOC injection is used in the setting of pheochromocytoma, give it in combination with an alpha-blocker, and only after the alpha-blocker has been initiated. (label Esmolol, Peringatan dan perhatian)

  • HidralazinvasodilatorMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • Isosorbid dinitratnitratMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • Isosorbid dinitrat dan hidralazinnitratMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • Isosorbid mononitratnitratMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • Metoprololpenyekat betaMinor

    Pheochromocytoma: Initiate therapy with an alpha blocker. (label Metoprolol, Peringatan dan perhatian)

  • Metoprolol dan hidroklorotiazidpenyekat betaMinor

    Pheochromocytoma: First initiate therapy with an alpha blocker. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Midodrinagonis alfa-adrenergikMinor

    Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride. (label Midodrin, Interaksi obat)

  • MinoksidilvasodilatorMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • NitrogliserinnitratMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • NitroprusidvasodilatorMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • PapaverinvasodilatorMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • RiosiguatvasodilatorMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • Treprostinilanalog prostaglandinMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • VerisiguatvasodilatorMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

Periksa Tamsulosin terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.